MyChart
MyChart is not for medical emergencies. If you have a medical emergency, call 911.
If you need help with MyChart, call us at 1-844-442-4278.
-
Appointments
Close
Request an Appointment
Please complete this secure form. The information you provide will help us assist you as efficiently as possible. A representative will contact you within one to two business days to help you schedule an appointment.
For questions, or to speak with someone directly, please call:
1-888-824-0200New Patients
To request an appointment, please use our secure online form. A representative will contact you within one to two business days to help you schedule an appointment.
Request an AppointmentCurrent Patients
Current patients may also use MyChart to request an appointment.
Contact Us
- MyChart
Drug delivery technique makes cancer immunotherapy more effective
Researchers in the Institute for Molecular Engineering at the University of Chicago (IME) have developed a new way to target immunotherapies and deliver them directly to tumors.
New checkpoint inhibitor shows promise in clinical trial for non-Hodgkin’s lymphoma
A novel antibody plus rituximab can block the “don’t eat me” signal, enabling macrophages to devour cancer cells.
Building on the promise of immunotherapy for melanoma
Architect Anwar Hakim turned to UChicago Medicine for a second opinion on treatment for advanced melanoma. Oncologist and melanoma expert Jason Luke, MD, suggested a Phase 1 clinical trial of a combination immunotherapy based on UChicago Medicine research. The treatment worked quickly and side effects were minimal, allowing Hakim to maintain a full work and travel schedule while receiving the therapy. "Six years ago, we didn’t have much to offer patients with advanced melanoma," Luke said. "Now we are seeing unbelievable responses to immunotherapy."
